Erica Schwartz is one step away from leading the CDC. Here’s what physicians should know
Industry Buzz
The public needed to hear clear commitments about how she would protect CDC guidance from political pressure. Too often, her stated commitments were incomplete, vague, or missing.
—National Public Health Coalition statement
She knows what she is doing and will stand against those who don’t. … There’s more to do to repair the damage that has been done to the US public health response, but this is a start.
—Bill Cassidy, senator and gastroenterologist
Erica Schwartz may soon take charge of the CDC. The more consequential question is whether she will actually be allowed to lead it.
The Senate HELP Committee voted to advance Schwartz’s nomination amid unusually direct concerns about political interference in federal public health.[] At her confirmation hearing, senators repeatedly pressed her on whether she would defend CDC guidance when the evidence conflicts with the priorities of HHS leadership. Her answers did not satisfy everyone.
The full Senate will vote on her resume, but physicians may judge her by something harder to measure: whether the CDC can still say what the science supports when the answer is politically inconvenient.
Who is Erica Schwartz?
Schwartz is a physician with an unusually broad government health background. She holds medical, public health, and law degrees and served as deputy surgeon general from 2019 to 2021.[][]
Before that, she spent years in military and federal public health, including serving as chief medical officer of the US Coast Guard, where she oversaw the service’s health system and operational public health programs.[]
Supporters—including Senator Bill Cassidy, Chairman of the HELP Committee—have pointed to her background as evidence that she could provide stability to an agency that has experienced considerable disruption over the past year.[]
Related: Trump taps another wellness influencer for top HHS role: Docs warn of expanded access to peptides, controversial therapiesHer positions on health policy
During her confirmation hearing, Schwartz largely presented herself as a traditional public health physician. She emphasized that public health guidance should be evidence-based, clear, and honest.[]
No topic received more attention during Schwartz’s confirmation process than vaccines. Her nomination comes after months of controversy surrounding federal vaccine policy, including changes to CDC vaccine communications and renewed federal interest in investigating a purported association between childhood vaccines and autism—a hypothesis that decades of large epidemiologic studies have failed to support.[][]
However, she generally avoided directly criticizing prior HHS decisions or committing to publicly oppose future directives from department leadership, a cautious approach that left some lawmakers unconvinced.[]
“The public needed to hear clear commitments about how she would protect CDC guidance from political pressure. Too often, her stated commitments were incomplete, vague, or missing,” the National Public Health Coalition said in a statement.[]
Cassidy, a gastroenterologist and a strong vaccine advocate, said he ultimately supported advancing her nomination after additional conversations and assurances regarding her commitment to science and agency independence.[]
“She knows what she is doing and will stand against those who don’t. As a sign of good faith, HHS has now modified the CDC’s autism and vaccines web page. There’s more to do to repair damage that has been done to the US public health response, but this is a start,” Cassidy said.[]
Related: How docs expect the vaccine policy shift will reshape primary care in 2026What physicians should watch
If confirmed, Schwartz will assume leadership of a CDC facing unusually high expectations. Clinicians will likely be watching several issues closely over the coming months:
Whether CDC vaccine recommendations remain grounded in established evidence
How much independence the agency exercises under HHS leadership
Whether the CDC can rebuild clinician and public trust
How the agency approaches emerging infectious disease threats and public health emergencies
Whether scientific advisory processes regain stability after a period of significant organizational change
The larger question for physicians is whether the nation’s premier public health agency can reestablish itself as a trusted source of evidence-based guidance during an era in which many of its recommendations have become politically contentious. That, more than any individual policy position, may define Schwartz’s tenure if she is confirmed.